tenofovir has been researched along with Trichomonas Vaginitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aubert, R; Dinh, C; Dobard, C; Garcia-Lerma, GJ; Hanson, D; Heneine, W; Henning, T; Kersh, E; Lipscomb, J; Makarova, N; McNicholl, J; Mitchell, J; Papp, J; Phillips, C; Taylor, A | 1 |
1 other study(ies) available for tenofovir and Trichomonas Vaginitis
Article | Year |
---|---|
Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.
Topics: Administration, Topical; Animals; Anti-HIV Agents; Chlamydia Infections; Coinfection; Disease Transmission, Infectious; Female; Macaca; Placebos; Plasma; Simian Acquired Immunodeficiency Syndrome; Tenofovir; Trichomonas Vaginitis; Vagina; Vaginal Creams, Foams, and Jellies | 2017 |